Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Estimize begins providing analyst data on private companies

Wednesday, June 12, 2013

amb
Leigh Drogen
Bailey McCann, Opalesque New York:

Earlier this year, Opalesque reported on Estimize, a company that is opening up analysis of public companies by letting any user contribute data. Through the community, Estimize has been able to beat sell-side analysis over 60% of the time. Now, the company is providing similar data on private companies.

"It's going to be really interesting to see how this is received, we got a lot of inbound on this so we rolled it out quickly, to be responsive," says Estimize Founder and CEO Leigh Drogen in an interview with Opalesque.

Estimize will start with the data of 7 big private companies, Twitter, Hulu, Square, Airbnb, Pinterest, Palantir, and Etsy. So far they've been using some historical data, and will revise as they get new information like an F1. Members of the analyst community on Estimize can also contribute their own data.

"What we're doing is giving the market a baseline, there are a set of analysts out there that cover private companies and the technology peanut gallery that can reliably put together an expectation of revenue for the next few quarters given current growth rates."

"There are things private companys are going to like about this and things they’re going to hate about it. If you’re twitter and you’re going to go public over the next couple of ye......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its